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Edited by Lukas HuberAbstract NogoA, a myelin-associated component, inhibits
neurite outgrowth. Nogo66, a portion of NogoA, binds to
Nogo66 receptor (NgR) and induces the inhibitory signaling.
LINGO-1 and p75 neurotrophin receptor (p75), the low-aﬃnity
nerve growth factor receptor, are also required for NogoA
signaling. However, signaling mechanisms downstream to Nogo
receptor remain poorly understood. Here, we observed that NgR
and p75 were colocalized in low-density membrane raft fractions
derived from forebrains and cerebella as well as from cerebellar
granule cells. NgR interacted with p75 in lipid rafts. In addition,
disruption of lipid rafts by b-methylcyclodextrin, a cholesterol-
binding reagent, reduced the Nogo66 signaling. Our results
suggest an important role of lipid rafts in facilitating the
interaction between NgRs and provide insight into mechanisms
underlying the inhibition of neurite outgrowth by NogoA.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Axon regeneration in the adult mammalian central nervous
system (CNS) is limited after injury due partially to the pres-
ence of inhibitory myelin-associated components [1,2]. Nu-
merous reports have implicated that an interaction of NogoA
on the oligodendrocyte surface with Nogo66 receptor (NgR)
on axons plays a key role in this process [3–6]. The extracel-
lular 66-residue segment of NogoA appears to possess the
ability to inhibit neurite growth in vitro and it is this portion of
Nogo that binds NgR [3,7–10]. NgR is a 473-residue, glyco-
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associated inhibitors: NogoA [3], myelin-associated glycopro-
tein (MAG) [11,12] and oligodendrocyte-myelinglycoprotein
(OMgp) [13,14]. The signal transduction of NgR has been
suggested to depend on the association with LINGO-1 and p75
neurotrophin receptor (p75), the low-aﬃnity nerve growth
factor (NGF) receptor, which may convey a signal into the cell
through Rho family GTPases and consequently promote
growth cone collapse and inhibit neurite extension [15–18].
Proteins and lipids in cell membrane form spatially diﬀer-
entiated microdomains. This lateral heterogeneity of the cell
membrane presumably results from preferential packing of
cholesterol and sphingolipids into platforms called ‘‘rafts,’’
onto which speciﬁc proteins attach on both sides of the lipid
bilayer. The unique lipid composition of rafts make them re-
sistant to non-ionic detergent extraction using Triton X-100
and can be isolated from non-raft domains [19–23]. Disruption
of the liquid ordered phase, by removal of cholesterol with b-
methylcyclodextrin (b-MCD) which selectively and rapidly
extract cholesterol from the plasma membrane [24–26], leads
to increased solubility of raft-associated proteins in Triton
X-100 [27]. Emerging evidence indicates that rafts serve as
platforms to concentrate signaling components and other
molecules [20,28]. They are implicated in various cellular
functions, including neuronal diﬀerentiation and survival [29],
neuritogenesis [30], neuronal cell adhesion, axon guidance
[31,32] as well as synaptic transmission [33].
Previous reports have demonstrated that HSVWTNgR
transfected in HEK293T cells and NgR, NgRH1 as well as
NgRH2 transfected in CHO-K1 cells localize primarily to lipid
rafts [34,35]. In addition, NgR and p75 localize primarily to
lipid rafts in cerebellar granule cells [36,37]. However, it is
unclear whether NgR is colocalized with p75 and RhoA in
vivo and whether lipid rafts play a role in Nogo66 signaling in
primary neurons. Here, we report that NgR, p75 and RhoA
are associated with lipid rafts in vivo. Disruption of lipid
rafts by depletion of cholesterol blocks the Nogo66 signal
transduction.2. Materials and methods
2.1. Reagents and antibodies
b-Methylcyclodextrin (M1356) was purchased from Sigma Chemical
Co. (St. Louis, MO). Optiprep was obtained as a 60% (wt/vol) stock in
water from AXIS-SHIELD PoC AS (Oslo, Norway). Rabbit poly-
clonal antibodies against human NgR (NGR11-A) were from Alpha
Diagnostic, International (San Antonio, TX). Rabbit polyclonalblished by Elsevier B.V. All rights reserved.
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son,WI). Mouse monoclonal antibodies against mouse ﬂotillin-1
(610820) were from BD Transduction Laboratories. Mouse mono-
clonal antibodies against human PSD-95 (05-427) were from Upstate
Biotechnology. Rabbit polyclonal antibodies against transferrin
receptor (TfR, sc-9099) and mouse monoclonal antibodies against
human RhoA (sc-418) were from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA).
2.2. Lipid rafts preparation
All experimental procedures were under the approval of the Ani-
mal Experiment Committee of Chinese Academy of Sciences. All
eﬀorts were made to minimize animal suﬀering and to reduce the
number of animals used. Lipid rafts were prepared as described
previously [38,39]. For in vivo samples, 3 g of forebrains and
cerebella from postnatal days 8 (P8) or adult rats (Sprague–Dawley)
were homogenized in 3 ml of buﬀer A containing 20 mM Tris/Cl
(pH7.4), 50 mM NaCl, 250 mM sucrose, 1 mM DTT, 0.5 mM so-
dium orthovanadate, 1 mM PMSF, 10 lg/ml aprotinin, 1 lg/ml
pepstain A, and 1 lg/ml leupeptin, respectively. After passing
through a 22G needle three times, homogenates were spun at 960·g
at 4 C for 10 min. The supernatant was collected and mixed with
OptiPrep (ﬁnal concentration of 35%, 4.8 ml) and placed at the
bottom of SW41 centrifugation tubes. The sample was overlaid with
three layers of OptiPrep (30%, 20%, and 5% in buﬀer A, 2.5 ml each)
and subjected to centrifugation at 200 000g at 4 C for 3 h. The
fraction (900 ll aliquot each) in the 5–20% interface was collected
and incubated with 600 ll of buﬀer A, containing 0.1% Triton X-100
(ﬁnal concentration) at 4 C for 20 min. The solubilized preparation
was mixed with OptiPrep (ﬁnal concentration of 35%, 3.6 ml) and
placed at the bottom of SW41 tubes. The sample was overlaid se-
quentially with 7.5 ml of 30% OptiPrep in buﬀer A containing 0.1%
Triton X-100 and another layer of buﬀer A containing 0.1% Triton
X-100 (1.5 ml). The gradient was centrifuged at 200 000g at 4 C
for 4 h and eight fractions (1.5 ml each) were collected from the top.
For in vitro samples, cerebellar granule cells from postnatal day 7
(P7) rats were cultured in chemically deﬁned Neurobasal medium
(Invitrogen) supplemented with B27 (Invitrogen) on poly-D-lysine
(Sigma) for 22–24 h. For some experiments, cells were treated with 10
mM b-MCD for 10 min before collection. Cell membrane was col-Fig. 1. NgR and p75 are associated with lipid rafts of the brain. (A, C) OptiPr
adult rat brains. Equal aliquots (15 ll) of the eight fractions were resolve
Flotillin-1 (fractions 1–2) and TfR (fractions 6–8) were used as loading cont
three independent experiments with similar results are shown. (B, D) Proteinlected and resuspended in 450 ll buﬀer B containing 50 mM Tris/Cl
(pH7.4), 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100, 1 mM
PMSF, 0.5 mM sodium orthovanadate, 1 lg/ml pepstatin A, 10 lg/ml
aprotinin, and 1 lg/ml leupeptin. After homogenized by passing them
through a 22G needle three times, the homogenates were mixed with
OptiPrep (ﬁnal concentration 35%, 1.08 ml), loaded at the bottom of
an SW41 centrifuge tubes and overlaid with 10.5 ml of 30% OptiPrep
in buﬀer B and 0.9 ml of buﬀer B. The ﬁnal concentration of Triton X-
100 of each layer was adjusted to 0.1%. The sample was centrifuged at
200 000g at 4 C for 4 h. Six fractions (2 ml each) were collected from
the top. For some experiments, cell pellet was lysed in 800 ll buﬀer C
containing 1% Triton X-100, 10% glycerol, 20 mM HEPES (pH 7.2),
100 mM NaCl, 1 mM PMSF, 1 mM sodium orthovanadate, 10 lg/ml
aprotinin, 1 lg/ml leupeptin, and 1 lg/ml pepstain A. The lysates were
centrifuged at 16 000g at 4 C for 15 min. The supernatant was
designated as the Triton-soluble fraction (S). The pellet was washed
with phosphate buﬀered saline (PBS), resuspended, and dissolved by
sonication in 200 ll buﬀer C containing 0.5% sodium dodecyl sulfate
(SDS). The supernatant was subsequently collected by centrifugation
at 16 000g at 4 C for 10 min and designated as the Triton-insoluble
fraction (IS).
2.3. Immunoprecipitation and immunoblotting
Triton-soluble and Triton-insoluble fractions (300 lg of protein)
were incubated directly with preimmuned IgG or indicated antibodies
in RIPA lysis buﬀer (PBS buﬀer, pH 7.4, containing 1% NP-40, 0.1%
SDS, 1% sodium deoxycholate, 10 mM EDTA, 10 lg/ml aprotinin, 1
lg/ml pepstatin A, 1 mM sodium orthovanadate, and 1 mM PMSF) at
4 C overnight on a rotating platform. They were then incubated with
protein-A-agrose beads at 4 C for 2 h on a rotating platform. Fol-
lowing centrifugation, beads were washed 4–5 times with RIPA lysis
buﬀer. Bound proteins were eluted with 2 SDS-sample buﬀer at 95
C. Protein samples from OptiPrep gradient fractions and immuno-
precipitation were resolved by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) and blotted onto PVDF membranes, which were incu-
bated in 5% non-fat dried milk dissolved in Tris/Cl buﬀered saline with
0.2% Tween (TBST) at room temperature for 1 h. Incubations with
primary antibodies were carried out overnight at 4 C. The membranes
were then incubated with the respective peroxidase-conjugated sec-
ondary antibody at room temperature for 1 h. Immunoreactive bandsep density gradient fractions were prepared from membranes of P8 and
d on SDS–PAGE and immunoblotted with the indicated antibodies.
rols as raft and non-raft markers, respectively. Representative blots of
concentrations in fractions in A and C.
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Rockford, IL). Intensities of the detected bands were quantiﬁed from
scanned immunoblots using Metamorph software (Universal Imaging
Corporation, West Chester, PA).
2.4. RhoA activity assays
Glutathione S-transferase (GST) and GST–Nogo66 (aa1026–1091)
were prepared as described previously [7,40]. Measurement of RhoA
activities was performed as described in the previous reports [41,42].
Cerebellar granule cells from P7 rat were grown (2 107 cells) on poly-
D-lysine substrate for 24 h. Cells were treated with GST (6 lg/ml) or
GST–Nogo66 (6 lg/ml) for 5 min. For some experiments, cells were
treated with 5 mM b-MCD for 45 min before stimulation with GST or
GST–Nogo66. 10% of the total volume of the cell lysate was used for
assessment of total RhoA content. The remaining lysate was diluted
with appropriate binding buﬀer (25 mM HEPES, pH7.5, 30 mM
MgCl2, 40 mM NaCl, 0.5% NP-40, 1 mM DTT, 1 mM PMSF, 10 lg/
ml aprotinin, 1 lg/ml leupeptin, and 1 lg/ml pepstain A) containing 20
lg of GST-Rho-binding domain of mouse rhotekin (GST-RBD)
coupled to glutathione beads for GTP-bound RhoA and incubated at
4 C for 2 h. Beads were then washed ﬁve times with binding buﬀer and
bound proteins were eluted with 2 SDS-sample buﬀer and detected
by immunoblotting using a mouse monoclonal anti-human RhoA
antibody.Fig. 2. Interaction of NgR with p75 in the detergent-insoluble fraction
of cerebellar granule cells. Triton-soluble (S) and Triton-insoluble
fractions (IS) were isolated from cultured cerebellar granule cells.
(A) Equal amounts (20 lg) of the fractions were resolved on SDS–
PAGE and immunoblotted with the indicated antibodies. (B, C, D)
Immunoprecipitation of Triton-soluble and Triton-insoluble fractions
(300 lg of protein) were carried out and then immnoblotted with the
indicated antibodies, respectively. Preimmuned IgG was used as a
negative control. The inputs of proteins used in B–D are shown in A.
Representative blots of two independent experiments with similar
results are shown.3. Results
3.1. NgR and p75 were present in the lipid raft fractions of the
brain
Insolubility in cold non-ionic detergents and ﬂotation on
sucrose density gradients or Optiprep density gradients are
the well-established criteria for identiﬁcation of lipid raft-
associated proteins [38,39,43]. Using these criteria, we tested
whether NgR and p75 were localized to lipid rafts in vivo. Cell
membrane mixtures from P8 and adult rat forebrains and
cerebella were isolated, respectively, from which lipid raft
fractions were prepared. Segregation of lipid raft from non-
lipid raft regions was conﬁrmed by separated distribution of
lipid raft-speciﬁc and non-lipid raft-speciﬁc markers in the
gradient. Flotillin-1, a lipid raft speciﬁc marker [44], mostly
ﬂoated to low density fractions, whereas TfR, a non-lipid raft
marker [45], stayed in high density fractions (Fig. 1A and C).
In P8 brains, when equal volumes (15 ll) of diﬀerent fractions
were analyzed, NgR was detected exclusively in the raft asso-
ciated fractions (Fig. 1A, panel 2), whereas p75 was detected in
all the fractions, with a low level of p75 in the raft associated
fractions and high amounts of p75 in the Triton X-100-soluble
bottom fractions (Fig. 1A, panel 3). Interestingly, in adult rat
brains, while NgR was still detected exclusively in the raft-
associated fractions (Fig. 1C, panel 2), p75 was not detected in
the soluble bottom fractions (Fig. 1C, panel 3). These results
indicated that localization of p75 into lipid rafts is possibly
correlated with developmental stages. Quantitative analysis
showed that the majority of the proteins were present in the
lipid raft and soluble fractions (Fig. 1B and D).
3.2. NgR interacted with p75 in detergent-insoluble fraction of
neurons
P75 is the coreceptor of NgR and interacts with NgR on the
cell surface of cerebellar granule cells and in cerebellum [15,16].
To investigate whether NgR interacts with p75 in detergent-
insoluble fraction, we isolated Triton-soluble (S) and Triton-
insoluble fractions (IS) from cultured cerebellar granule cells.
Consistent with the above results, NgR proteins were detected
exclusively in the Triton-insoluble fraction, whereas p75 wasfound in both the Triton-soluble and Triton-insoluble frac-
tions. PSD-95, another raft-associated protein, was also found
in both the Triton-soluble and Triton-insoluble fractions
(Fig. 2A, right). Flotillin-1 was detected in the two fractions,
with a majority of it in the Triton-insoluble fraction (Fig. 2A,
left). Based on these results, the Triton-soluble and Triton-
insoluble fractions were then processed for immunoprecipita-
tion, respectively. The immunoprecipitation results showed an
interaction between p75 and NgR in the Triton-insoluble
fraction (Fig. 2B and C). However, PSD-95 did not interact
with p75 and NgR in the Triton-insoluble fraction (Fig. 2D).
These results indicate that lipid rafts might act as platforms for
the Nogo66-mediated signaling.
Fig. 3. Disruption of lipid rafts reduces NgR and p75 in lipid rafts. (A) OptiPrep density gradient fractions were prepared from cerebellar granule
cells of P7 rats. Equal aliquots (30 ll) of the six fractions were resolved on SDS–PAGE and immunoblotted with the indicated antibodies. Control,
cells without any treatment. +b-MCD, cells treated with 10 mM +b-MCD for 10 min. All of these Western blots used the samples from the same
OptiPrep gradient centrifugation. Representative blots of two independent experiments with similar results are shown. (B, C) Protein concentrations
in fractions in A.
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p75 in the lipid rafts
To conﬁrm that the detergent insolubility of NgR and p75 is
dependent on their localization to lipid rafts, we used b-MCD
to disrupt rafts. Lipid raft fractions were prepared from cul-
tured cerebellar granule cells. Consistent with the previous
report, when equal volumes (30 ll) of diﬀerent fractions were
analyzed, NgR was detected exclusively in the lipid raft frac-
tions, whereas p75 was detected both in the lipid raft and non-
lipid raft fractions (Fig. 3A, left). In contrast, in neurons
treated with 10 mM b-MCD for 10 min before lipid raft
preparation, the level of NgR and p75 in lipid rafts were de-
creased while a larger portion of NgR and p75 was detected in
the soluble fraction. Meanwhile, the level of ﬂotillin-1 was also
increased in the non-lipid raft fractions (Fig. 3A, right).
Quantitative analysis showed that the majority of the proteins
were present in the lipid raft and soluble fractions (Fig. 4B and
C). These results suggested that the integrity of lipid rafts
might be important for Nogo66 signaling.
3.4. Disruption of lipid rafts inhibited Nogo66 signaling
Previous studies have shown that Nogo66 induced inhibition
of neurite outgrowth of cerebellar granule cells requires the
involvement of the RhoA-associated kinase ROCK [40]. In
endothelial, RhoA GTPase is localized to caveolae-enriched
membrane domains [46]. To investigate whether RhoA is
present in lipid rafts in CNS, we used mouse anti-human
RhoA monoclonal antibodies to test the lipid raft and non-
lipid raft fractions segregated from adult forebrains and cere-
bella. As expected, we observed that there was colocalization
of RhoA with ﬂotillin-1 in the lipid rafts (Fig. 4A). To further
determine whether NgR in lipid rafts is important for Nogo66
signaling, we added soluble Nogo66 to stimulate cultured
cerebellar granule cells and measured the amounts of cellular
active GTP-bound RhoA. GST–Nogo66 induced a marked
activation of RhoA after stimulation for 5 min. We thentreated cerebellar granule cells with 5 mM b-MCD for 45 min
to disrupt lipid rafts before stimulation with GST–Nogo66 and
examined the RhoA activation in response to GST–Nogo66.
As shown in Fig. 4, GST–Nogo66 no longer induced obvious
RhoA activation compared to control after pretreatment with
b-MCD. Meanwhile, b-MCD itself did not aﬀect the normal
basal level of RhoA activation (Fig. 4B and C). Taken to-
gether, these results indicate that lipid rafts are essential for
Nogo66 signaling.4. Discussion
In this study, we have shown that NgR, p75 and RhoA were
present in the lipid rafts of the brain. NgR was found to in-
teract with p75 in detergent-insoluble fraction. Acute choles-
terol depletion of cerebellar granule cells prior to detergent
extraction reduced the level of NgR and p75 in lipid rafts. In
addition, Nogo66 induced RhoA activity was abolished by b-
MCD treatment.
Lipid rafts are characterized by their accumulation of cho-
lesterol and sphingolipids. Typically, this fraction is enriched
in GPI-linked glycoproteins [30]. NgR is predominantly ex-
pressed in neurons and their axons and is attached to the outer
leaﬂet of the plasma membrane by a GPI moiety in the CNS
[4,47]. Using well-established biochemical techniques to isolate
lipid rafts, we have demonstrated that NgR, p75 and RhoA
were localized to these membrane microdomains (Figs. 1–4).
Interestingly, while NgR was detected exclusively in the lipid
raft fractions at the two developmental stages examined, p75
showed a developmental change of localization into lipid rafts
(Fig. 1). Similar developmental translocation of L1 and Ncad
into lipid rafts has been reported previously [44]. The mecha-
nism is possibly in part dependent on palmitoylation at their
membrane-spanning domain [48]. A similar palmitoylation site
is present in p75 at its membrane-spanning domain [49] and it
Fig. 4. b-MCD treatment of neurons blocks RhoA activation induced
by GST–Nogo66. (A) OptiPrep density gradient fractions were pre-
pared from membranes of adult rat brains. Equal aliquots (15 ll) of
the eight fractions were resolved on SDS–PAGE and immunoblotted
with indicated antibodies. (B) Soluble GST (6 lg/ml) and GST–
Nogo66 (6 lg/ml) were used to stimulate cerebellar granule cells in
culture for 5 min or treated with 5 mM b-MCD for 45 min before
stimulation with GST and GST–Nogo66, respectively. The amounts of
cellular active GTP-bound RhoA were measured. (C) RhoA activities
are indicated by the amount of GST-RBD bound RhoA normalized
to the amount of total RhoA content in the lysates. Results are
meansS.E.M. from three experiments.
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the similar mechanism. A more recent report suggested that a
lipid-dependent mechanism was involved in the recruitment of
neuronal Src to lipid rafts in the brain [50]. Their ﬁndings may
suggest an alternative mechanism of p75 translocation.
Though the physiological importance remains unknown, we
postulate that p75 translocation to lipid rafts might be corre-
lated with more eﬃcient transduction for signaling and thus
provide a cue for studying the mechanisms of poorer axonal
regeneration in older rats.
The importance of p75 in mediating NgR-dependent inhib-
itory signaling [15,16] is further conﬁrmed by our co-immu-
noprecipitation results showing an interaction of p75 with
NgR in detergent-insoluble fractions (Fig. 2). Considering the
exclusive presence of NgR in the lipid rafts, we infer that lo-
calizing in lipid rafts may facilitate the interaction of NgR and
p75 as well as with other molecules involved in the signal
transduction.
Cholesterol is critical to the integrity of caveolae and other
lipid raft structures. Cholesterol depletion will eventually lead
to the disruption of lipid rafts and caveolae [51]. b-MCD is a
cholesterol-binding reagent that can acutely deplete cellular
cholesterol [21,52]. In our study, we found that b-MCDtreatment dramatically reduced the amounts of NgR and p75
in the lipid raft fractions and thus may aﬀect the signal
transduction of Nogo66.
Activation of the small GTPase RhoA has been shown to be
a crucial step in the signal transduction of inhibitory cues in
various neurons [53,54]. The most important eﬀector of
GTPases RhoA in the growth cone is probably the serine–
threonine kinase Rho-kinase ROCK [55]. Inhibition of the
RhoA–ROCK pathway greatly improved neurite outgrowth
response of cerebellar granule cells [40]. Previous studies
demonstrate that small GTPase Rho, Ras, c-Src and FAK are
present in raft fractions [56,57]. In our study, we also detected
RhoA in the detergent-insoluble fractions of the brain. In
addition, we found that activation of RhoA in cerebellar
granule cells by GST–Nogo66 was inhibited by b-MCD. Our
results demonstrate that disruption of lipid rafts blocked the
Nogo66 signaling and may consequently inhibit the neurite
outhgrowth.
Based on these results and previous data, we suggest the
following mode of action for Nogo66. Nogo66 binds NgR on
the cell surface and simultaneously or subsequently interacts
with p75 and other co-receptors in the lipid rafts. These in-
teractions induce activation of RhoA and the upregulation of
RhoA activity results in inhibition of neurite outgrowth. As
LINGO-1 was recently reported to be an important compo-
nent of the NgR1/p75 receptor complex, it remains to be in-
vestigated whether it is also located in lipid rafts. In addition,
previous report has implied a mechanism of PKA regulated
location of p75 into lipid rafts [37]. Considering the relatively
low level of p75 and RhoA in the lipid rafts in younger rat
brains (data not shown), it remains to be investigated whether
p75 and RhoA would be recruited to lipid rafts by Nogo66
stimulation for more eﬃcient signaling.
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